Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

AZA1

🥰Excellent
Catalog No. T61448Cas No. 1071098-42-4
Alias Rac1/Cdc42-IN-1

AZA1 (Rac1/Cdc42-IN-1) is a potent dual inhibitor of Rac1 and Cdc42. AZA1 induced apoptosis of prostate cancer cells and inhibited cell proliferation, migration and invasion.

AZA1

AZA1

🥰Excellent
Purity: 98.59%
Catalog No. T61448Alias Rac1/Cdc42-IN-1Cas No. 1071098-42-4
AZA1 (Rac1/Cdc42-IN-1) is a potent dual inhibitor of Rac1 and Cdc42. AZA1 induced apoptosis of prostate cancer cells and inhibited cell proliferation, migration and invasion.
Pack SizePriceAvailabilityQuantity
1 mg92 €In Stock
5 mg234 €In Stock
10 mg377 €In Stock
25 mg629 €In Stock
50 mg897 €In Stock
100 mg1.216 €In Stock
500 mg2.441 €In Stock
1 mL x 10 mM (in DMSO)258 €In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "AZA1"

Select Batch
Purity:98.59%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
AZA1 (Rac1/Cdc42-IN-1) is a potent dual inhibitor of Rac1 and Cdc42. AZA1 induced apoptosis of prostate cancer cells and inhibited cell proliferation, migration and invasion.
In vitro
AZA1 (Rac1/Cdc42-IN-1) (2-10 μM; 72 hours) impedes the proliferation of human 22Rv1 prostate cancer cells, diminishes phosphorylation of PAK1, AKT, and BAD in EGF-stimulated 22Rv1 cells (2-10 μM; 24 hours), and obstructs Rac1 and Cdc42-dependent cell cycle progression (10 μM; 24 hours). AZA1 also inhibits Rac1 and Cdc42-dependent migration of 22Rv1, DU 145, and PC-3 prostate cancer cells, impacting cell motility and actin reorganization through PAK1/2 phosphorylation suppression.
In vivo
AZA1 (Rac1/Cdc42-IN-1) (100 μg; i.p.; daily for 2 weeks) effectively suppresses human 22Rv1 xenograft growth in 5-week-old athymic nu/nu (nude) mice and improves survival, with a significant impact on tumor growth suppression.[1]
AliasRac1/Cdc42-IN-1
Chemical Properties
Molecular Weight368.43
FormulaC22H20N6
Cas No.1071098-42-4
SmilesCc1cc2cc(Nc3ccnc(Nc4ccc5[nH]c(C)cc5c4)n3)ccc2[nH]1
Storage & Solubility Information
StorageShipping with blue ice.
Solubility Information
DMSO: 60 mg/mL (162.85 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7142 mL13.5711 mL27.1422 mL135.7110 mL
5 mM0.5428 mL2.7142 mL5.4284 mL27.1422 mL
10 mM0.2714 mL1.3571 mL2.7142 mL13.5711 mL
20 mM0.1357 mL0.6786 mL1.3571 mL6.7855 mL
50 mM0.0543 mL0.2714 mL0.5428 mL2.7142 mL
100 mM0.0271 mL0.1357 mL0.2714 mL1.3571 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy AZA1 | purchase AZA1 | AZA1 cost | order AZA1 | AZA1 chemical structure | AZA1 in vivo | AZA1 in vitro | AZA1 formula | AZA1 molecular weight